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Abstract Clostridial neurotoxins embrace a family of ex-
tremely potent toxins comprised of tetanus toxin (TeNT) and
seven different serotypes of botulinum toxin (BoNT/A^G). The
L-trefoil subdomain of the C-terminal part of the heavy chain
(HC), responsible for ganglioside binding, is the most divergent
region in clostridial neurotoxins with sequence identity as low as
15%. We re-examined the alignment between family sequences
within this subdomain, since in this region all alignments
published to date show obvious inconsistencies with the L-trefoil
fold. The final alignment was obtained by considering the general
constraints imposed by this fold, and homology modeling studies
based on the TeNT structure. Recently solved structures of
BoNT/A confirm the validity of this structure-based approach.
Taking into account biochemical data and crystal structures of
TeNT and BoNT/A, we also re-examined the location of the
putative ganglioside binding site and, using the new alignment,
characterized this site in other BoNT serotypes. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Clostridial neurotoxins, the most potent toxins known, are
a family of homologous proteins produced by anaerobic bac-
teria of the genus Clostridium [1,2]. This family comprises
tetanus neurotoxin (TeNT), the casual agent of the patholog-
ical condition known as tetanus, made by Clostridium tetani,
and botulinum neurotoxins (BoNTs), produced as seven im-
munologically distinct serotypes (BoNT/A^G) by Clostridium
botulinum and other species of the same genus, responsible for
the neuroparalytic condition, botulism [3,4]. The process of
cell intoxication is achieved via a four-step mechanism [5,6] :
(1) binding to speci¢c neuronal receptors, (2) internalization
into endosome-like vesicular organelles through receptor-
mediated endocytosis, (3) membrane translocation which re-
quires acidi¢cation of the vesicle lumen, and (4) modi¢cation
of the cytosolic target. The main di¡erence between TeNT
and the BoNTs in this process is that, after binding at the
presynaptical neuronal membrane, TeNT undergoes retro-
grade axonal transport to act in the central nervous system
[7].
Clostridial neurotoxins are synthesized as single polypeptide
chains (V150 kDa), subsequently cleaved at a single point to
produce two chains: a heavy (H) chain (V100 kDa) and a
light (L) chain (V50 kDa), linked through a disul¢de bond
[8]. The C-terminal part of the H chain (HC) is responsible for
neurospeci¢c binding at the presynaptic membrane of the neu-
romuscular junction [9,10], while the N-terminal fragment of
the H chain (HN) plays a critical role in translocation of the
catalytic L chain across the vesicle membrane into the cytosol
[11]. HC demonstrates high a⁄nity for glycolipid receptors on
the neuronal surface mainly from a ganglioside series [12].
TeNT and some of the BoNTs show a preference for ganglio-
side GT1b [13^16]. However the interaction between this HC
and the presynaptic nerve ending is proposed to also occur
through an as yet unidenti¢ed protein receptor [17]. It is as-
sumed that di¡erences in this protein receptor could be the
reason for alternate localization of TeNT and BoNTs. The L
chain, which belongs to a zinc-dependent protease family [18],
catalyzes proteolysis of a speci¢c, single protein involved in
synaptic vesicle membrane fusion at a unique site inside the
neuronal cytosol [19]. The result of this cleavage is inhibition
of neurotransmitter release, leading to paralysis [20].
Although TeNT is e¡ective on several types of synapses
leading to spastic paralysis, while BoNTs act on the choliner-
gic nerve endings causing £accid paralysis, these two subfam-
ilies of neurotoxins exhibit signi¢cant sequence similarity and
structural relatedness [21^23]. Two independently solved crys-
tal structures of HC of TeNT revealed the general architecture
of the receptor binding domain [24,25]. This domain com-
prises two subdomains: the N-terminal subdomain exhibiting
a jelly roll motif and the C-terminal subdomain forming a
L-trefoil motif. The C-terminal subdomain of HC is responsi-
ble for ganglioside binding; moreover, the approximate loca-
tion of the ganglioside binding site within the C-terminal sub-
domain has been implicated by many experimental studies
[26^29]. Sequence similarity for clostridial neurotoxins within
this subdomain is very low, as is typical for proteins exhibiting
the L-trefoil fold [30,31]. In this region, all previously reported
alignments of clostridium neurotoxins show some obvious in-
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consistencies with the crystal structures of HC TeNT, as well
as the general architecture of the L-trefoil fold [22^24]. Con-
sequently, we re-examined the alignment of the clostridial
neurotoxin sequences in the L-trefoil subdomain with due
consideration of sequence constraints imposed by this fold,
and the comparative modeling studies based on the TeNT
structure.
After these modeling studies had been completed, two ex-
perimental crystal structures of intact BoNT/A were reported
[32,33]. This enabled veri¢cation of our proposed alignment
and provided a very useful test for validation of the applied
theoretical methods and modeling strategy. Taking into ac-
count structural positions of the key residues shown in pre-
vious experimental studies to be responsible for the ganglio-
side binding in both TeNT and BoNT/A, we re-examined the
location of the putative ganglioside binding pocket within the
C-terminal subdomain of HC. It has now been shown by a
crystallographic study of HC TeNT complexed with di¡erent
carbohydrate units that this pocket is able to bind lactose [34].
Our sequence-to-structure alignment for the clostridial neuro-
toxin family within the L-trefoil subdomain provides annota-
tion at the level of individual residues of this putative ganglio-
side binding site in di¡erent serotypes of BoNT.
2. Materials and methods
2.1. Analyzing structural determinants of the L-trefoil subdomain
To produce an alignment consistent with the general architecture of
the L-trefoil fold, we ¢rst identi¢ed 12 regions in the TeNT structure
that are structurally conserved in this fold. These structurally con-
served regions were previously determined from the superposition of
the molecular structures of 13 di¡erent L-trefoil domains from pro-
teins sharing very little sequence similarity [31], namely: ricin, abrin,
acidic ¢broblast growth factor, basic ¢broblast growth factor, hisac-
tophilin, interleukin 1 receptor antagonist protein, interleukin 1L,
winged bean albumin 1, Kunitz trypsin inhibitor and amaranthin.
The 12 conserved structural motifs of the L-trefoil fold containing
60 residues include six L-strands forming a barrel and six L-strands
forming hairpins that close the bottom of the barrel. The major se-
quence requirements of this fold are large or medium size hydropho-
bic residues at 18 buried sites [30]: 12 residues from barrel strands
which form the central and bottom layers, and six residues from hair-
pins that pack against the bottom layer. However, as shown more
recently [31], residues involved in forming the central layer are
much less restricted in terms of the amino acid type, reducing the
number of conserved sites requiring exclusively bulky hydrophobic
residues to 12.
2.2. Generating sequence-to-structure alignment
Taking into account the high sequence divergence of clostridial
neurotoxins in the C-terminal part of HC, we applied a modeling
strategy that combines classical sequence alignment techniques with
homology modeling studies. Initially, the CLUSTAL W program [35]
was used to generate multiple sequence alignments of the C-terminus
fragment of HC of clostridial neurotoxins. Sequences of BoNT/C and
BoNT/D were then excluded from the consideration, as they were too
dissimilar from the rest of the family to obtain unambiguous align-
ment. In the CLUSTAL W alignment process neither secondary struc-
ture nor gap penalty masks were used. Opening and extension gap
penalties were systematically changed to decide where the conserved
parts of the alignment are located. This procedure revealed very stable
parts of the alignment spanning eight structurally conserved regions
of the TeNT L-trefoil structure: Tyr1128^Pro1132, Lys1138^Leu1142,
Lys1174^Lys1178, Ile1196^Val1200, His1207^Tyr1211, Gly1266^
Thr1270, Asp1282^Ala1286, and Asp1302^Val1306, with bulky hy-
drophobic residues at appropriate positions. For the remaining four
structurally conserved regions in the TeNT L-trefoil structure:
Asp1147^Leu1151, Arg1223^Val1227, Lys1239^Val1243, Val1253^
Leu1257, where sequence similarity between BoNTs and TeNT was
negligible, we considered several variants of the alignment. Taking
into account the conservation of large/medium size hydrophobic ami-
no acids at the 12 speci¢c positions in L-trefoil fold enabled us to
reduce the number of possible variants of the alignment. The remain-
ing alignment variants were tested using the comparative modeling
technique. For these cases 3D molecular models of the conserved
L-trefoil core were built for all the considered serotypes of BoNT
with the homology module of InsightII program package (MSI Inc.,
San Diego, CA, USA) using the TeNT structure [25] (PDB code:
1A8D) as a template. Positions of the conserved TeNT backbone
atoms remained unchanged in the modeling procedure. Side chain
conformations were generated either manually or using the SCWRL
program with the backbone conformation-dependent side chain ro-
tamer library [36]. Models were then subjected to detailed evaluation,
mainly by visual inspection of the molecular structures to detect im-
proper packing of residues, including buried unpaired donors/accep-
tors or exposed hydrophobic side chains. In addition, a detailed anal-
ysis was performed on the side chain packing in the core built from 18
mainly hydrophobic residues (amongst them 12 exclusively bulky hy-
drophobic residues) required for integrity of the L-trefoil fold. This
allowed us to exclude molecular models with cavities or steric clashes
that could not be removed with the rotamer search procedure, indi-
cating either too loose or too tight packing, respectively. Such a 3D
evaluation procedure enabled selection of the best alignment for the
structurally conserved regions possessing very low sequence similarity.
In the loop regions, where no sequence similarity was detected, the
multiple sequence alignment was corrected manually to maximally
preserve the interactions observed in the TeNT structure.
3. Results and discussion
3.1. Structure-based alignment for the clostridium neurotoxin
family
Alignment of the target protein sequence with the template
structure remains the single most signi¢cant step in the com-
parative modeling of protein structure [37]. Such alignments
are particularly error-prone in cases of low sequence similar-
ity. One of the major goals of this study was to investigate
whether a comparative modeling approach, combined with
careful consideration of 3D constraints, would result in struc-
turally correct alignments for the clostridium neurotoxin fam-
ily. Ten sequences of BoNT: BoNT/A, BoNT/A (Inf), BoNT/
B (GpI), BoNT/B (GpII), BoNT/E, BoNT/E (buty), BoNT/F
(GpI), BoNT/F (GpII), BoNT/F (bara), BoNT/G were aligned
against the C-terminal fragment of HC of TeNT. The percent-
age of identical residues within the L-trefoil domain, when
making pairwise comparisons between TeNT and BoNT se-
quences, ranged from 30% to as low as 15%. Taking into
account the general sequence requirements of the L-trefoil
fold, and the available structural information for TeNT, the
initial alignment was improved in regions where classical se-
quence-based algorithms were unable to detect any sequence
similarity. The ¢nal alignment is shown in Fig. 1.
Recently, two crystal structures of intact BoNT/A were
solved [32,33], enabling a rigorous veri¢cation of our model-
ing approach. As assumed in our study, structurally conserved
regions of the L-trefoil fold observed in TeNT are also present
in BoNT/A (Fig. 2a). These regions superimpose in both
structures with the r.m.s. deviation of 0.91 Aî for 60 CK posi-
tions. The main di¡erences between these two structures are
located in loop regions, where the sequences are most diver-
gent. However, it should be noted that Cys1234, the ¢rst res-
idue of the structurally conserved region taking part in form-
ing the barrel, plays a structurally di¡erent role than the
corresponding Val1253 in TeNT (Fig. 2b). Speci¢cally, the
side chain of Cys1234 is not involved in forming the central
layer of the hydrophobic barrel core, but forms a disul¢de
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bridge with Cys1279. This observation is consistent with the
revised L-trefoil sequence requirements [31], indicating that
this position is much less restricted in the choice of residue
type. The role of Cys1234 is taken over by the adjacent
Lys1235, which supports hydrophobic interactions in the
core with the aliphatic portion of its side chain. The corre-
sponding pairs of cysteine residues also occur in BoNT/B,
BoNT/E, BoNT/F, and BoNT/G, where similar disul¢de
bonds are most likely formed as well.
The sequence-to-structure alignment of BoNT/A and TeNT
obtained in this study is in complete agreement with the struc-
tural superposition of these two neurotoxins. This agreement
extends even beyond the L-trefoil fold core into those loop
regions that are structurally similar in BoNT/A and TeNT.
Consequently, at the very low sequence similarity observed in
this case, including structural information in the modeling
strategy was the most important feature leading to the correct
alignment. It should be noted that, within some conserved
regions of the L-trefoil fold, the TeNT shares little or no
similarity with the BoNT sequences, while in the same regions
some similarity among BoNTs does exist. Thus the main dif-
¢culty in generating the sequence-to-structure alignment con-
sisted of aligning the BoNT sequences with the previously
solved structure of TeNT. Con¢rmation of the correctness
of our modeling-derived alignment by the crystallographic
studies of BoNT/A makes it reasonable to expect that the
alignment for the remaining serotypes of BoNT is also cor-
rect. It should be emphasized that, even with the availability
of the BoNT/A 3D structure, obtaining a structurally consis-
tent alignment for the BoNT sequence family cannot be con-
sidered a trivial problem. To our knowledge, all the align-
ments of clostridial neurotoxins published to date have
obvious errors in regions of low sequence similarity that are
nonetheless structurally conserved in the L-trefoil fold [22^24].
This also applies to the alignment reported together with the
crystal structure of BoNT/A [33]. This alignment is not only
inconsistent with the general sequence requirements of the
L-trefoil fold, but also with the superposition of the TeNT
Fig. 1. Sequence alignment of TeNT and di¡erent serotypes of BoNT in the L-trefoil region. Conserved residues shared by at least 60% of all
sequences are highlighted in blue (identical) and green (similar). Locations of the secondary structure elements in TeNT and BoNT/A, as de-
¢ned by DSSP [42], are marked beneath and above the sequences, respectively; L-strands are represented as arrows, and K-helices as rectangles.
Colored L-strands participate in either forming the barrel (brown) or closing the barrel (yellow). Twelve structurally conserved regions common
to the L-trefoil fold are enclosed in red rectangles and 18 key structural positions for this fold are denoted by * (central layer), U (bottom
layer) and + (hairpin closure, which packs against the bottom layer). Positions of amino acids forming the putative ganglioside binding pocket
in the TeNT and BoNT/A structures are indicated by magenta dots beneath and above the sequences, respectively. Sequence numbering for the
clostridial neurotoxins includes the N-terminal Met residue, except for BoNT/A, where numbering is as in the crystal structure [32].
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and BoNT/A structures. This con¢rms previous observations
that, in cases where proteins share very little sequence simi-
larity, the classical sequence-based alignment techniques are
extremely error-prone [38]. As a result, such alignments can-
not provide reliable information at the level of individual
residues regarding the L-trefoil subdomain in other serotypes
of BoNT.
3.2. Ganglioside binding
Both biochemical and structural studies indicate that the
L-trefoil subdomain of clostridial neurotoxins is involved in
ganglioside binding. At the same time there is considerable
confusion in the literature about the location and the phys-
icochemical properties of this putative binding site.
Initially, based on the TeNT crystallographic structure, it
was proposed that a shallow surface pocket formed partly by
the C-terminal residues Val1306^Glu1310 might be responsi-
ble for ganglioside binding [24], since their deletion in trunca-
tion studies completely abolished ganglioside binding [26].
Recently, more direct experiments identi¢ed a di¡erent region
involved in ganglioside binding. A study using novel ganglio-
side photoa⁄nity ligand implicated His1293 in TeNT [27]. A
similar region in BoNT/E containing His1228, which corre-
sponds to His1293 in TeNT, was also identi¢ed by using
monoclonal antibodies [28]. In addition, it was shown that
ganglioside quenches tryptophan £uorescence, suggesting
that a tryptophan must be part of the ganglioside binding
site in BoNT/A [29]. The X-ray structure of BoNT/A revealed
that only one of the three tryptophan residues in the C-ter-
minal region of the L-trefoil subdomain, Trp1265, is exposed
to solvent [33]. Both Trp1265 in BoNT/A (Trp1289 in TeNT)
and His1293 in TeNT (Gln1269 in BoNT/A) are located close
to one another at i and i+4 positions of the same K-helix, but
are on the opposite side of the L-trefoil subdomain relative to
the C-terminal residues of TeNT (Val1306^Glu1310) removed
in the truncation study [26]. This apparent discrepancy be-
tween two sets of experimental data can be resolved if removal
of Val1306, the terminal residue of the last strand of the
L-trefoil core, destroys the integrity of the whole L-trefoil
subdomain, including the ganglioside binding site, as sug-
gested by Emsley et al. [34].
Surprisingly, in spite of the identi¢cation of His1293 in
TeNT and Trp1265 in BoNT/A as part of the putative gan-
glioside binding site, there has been considerable confusion
regarding surface location, shape and electrostatic properties
of this site. A discussion by Lacy and Stevens [33] regarding
the deep, positively charged interdomain cleft in BoNT/A, left
others [34] thinking that this cleft was being proposed as the
ganglioside binding site. The cleft in the subdomain interface
is formed partly by a loop (Lys1244^Ser1252 in TeNT and
Ser1224^Lys1233 in BoNT/A), whose conformation di¡ers
signi¢cantly in TeNT and BoNT/A structures. As proposed
by Lacy and Stevens [33], the large di¡erence in shape and
electrostatic properties of this cleft might contribute to alter-
nate localization of these two toxins. If so, we suggest that the
role of this cleft is to interact with the still unidenti¢ed protein
receptor rather than the ganglioside.
The two key residues implicated in ganglioside binding in
both structures are located on the rim of a shallow surface
pocket, which is distinct from the interdomain cleft (Fig. 3a).
Residues forming this pocket in TeNT and BoNT/A struc-
tures are marked in Fig. 1. Positions of most of these TeNT
and BoNT/A residues are structurally conserved, as they come
from conserved secondary structure elements, or from those
parts of loops which are also structurally similar. These struc-
turally equivalent residues superimpose closely, with the r.m.s.
deviation of 0.68 Aî for their CK positions.
The importance of this pocket has now been con¢rmed by a
crystallographic study showing that this region in the TeNT
structure binds lactose [34]. Furthermore, the orientation of
the bound lactose would allow accommodating the rest of the
ganglioside structure without any steric hindrance (Fig. 3b).
Although the same study identi¢ed other possible binding
sites within the L-trefoil subdomain for several di¡erent gan-
Fig. 2. Comparison of the TeNT and BoNT/A L-trefoil subdomains, superimposed within structurally conserved regions. a: Entire L-trefoil re-
gion in TeNT (cyan) and BoNT/A (white). Structurally conserved regions common to this fold are colored brown and yellow in both structures
for the barrel and hairpins, respectively. b: Enlarged L-trefoil core for TeNT (thick) and BoNT/A (thin). Side chains of 18 key residues forming
the core are shown as sticks, including residues from the central layer (green), bottom layer (magenta) and hairpin closure (blue). Labeled are a
pair of cysteine residues and lysine that contribute to the unusual packing in the L-trefoil core of BoNT/A.
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glioside subunits, it remains to be determined if these subunits
actually bind in the same manner when they are a part of the
intact ganglioside receptor. Taking into account the agree-
ment between structural and biochemical data, we suggest
that the lactose binding site plays the most important role
in the ganglioside recognition and binding.
In contrast to the interdomain cleft, the shape and the elec-
trostatic properties of the putative ganglioside binding site in
both toxins appear to be much more similar (Fig. 3). In par-
ticular, in both toxins the surface of this pocket does not have
any signi¢cant electrostatic charge, but the bottom of the
pocket possesses a similar hydrophilic patch. This highly hy-
drophilic part of the surface is formed in both toxins by pairs
of the structurally equivalent residues from the conserved sec-
ondary structure elements. In TeNT this includes side chain
oxygen atoms of Asp1222, Ser1287, Tyr1290 (Glu1202,
Ser1263, Tyr1266 in BoNT/A), the main chain carbonyl group
of Thr1270 (Phe 251 in BoNT/A) and the main chain amide
group of Gly1300 (Gly1278 in BoNT/A). All these polar
atoms make hydrogen bonds with oxygen atoms of the galac-
tose ring in TeNT [34]. This ¢nding suggests the importance
of this conserved hydrophilic surface pattern at the bottom of
the pocket, which seems to play the key role in binding of the
internal galactose ring of ganglioside. Another important
common feature of this putative ganglioside binding site in
TeNT and BoNT/A is a hydrophobic wall formed by a key
tryptophan residue. As shown in the TeNT structure [34] this
Trp1289 plays a critical role in maintaining hydrophobic in-
teractions between the toxin and the ganglioside galactose
ring. Similar stacking interactions between a tryptophan side
chain and a galactose ring have been observed both in cholera
toxin [39] and heat-labile enterotoxin [40,41] structures com-
Fig. 3. Comparison of binding domains for TeNT and BoNT/A. a: GRASP [43] representation of the molecular surfaces colored by electro-
static potential: positive in blue and negative in red. b: Enlarged molecular surfaces in the region of the putative ganglioside binding site. The
putative binding site is colored by atom type: red (oxygen), blue (nitrogen) and green (carbon). Labeled are residues contributing to the con-
served features of the putative ganglioside binding pocket. Bound lactose unit is shown as balls and sticks. Black arrows indicate positions of
the remaining parts of ganglioside receptor: cer, ceramide; sia, sialic acid; GalNAc, N-acetylgalactosamine. Lactose in the BoNT/A structure
was modeled based on the lactose^TeNT complex [34].
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plexed with part of the ganglioside receptor, arguing for the
importance of such interaction in recognition and binding.
Only a few residues in this putative ganglioside binding
pocket, including Ser1287, Trp1289, Tyr1290 and Gly1300
in TeNT, are absolutely conserved throughout the clostridial
neurotoxin family (without consideration of BoNT/C and
BoNT/D). In addition to these four fully conserved residues,
Asp1222 in TeNT is replaced by glutamic acid in most of
BoNT serotypes. Interestingly, all these residues were found
to interact with the galactose unit. Consequently, the conser-
vation of these ¢ve residues seems to be, as discussed above, a
common recognition pattern responsible for galactose bind-
ing.
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